Cargando…

Reinfections in COVID-19 Patients: Impact of Virus Genetic Variability and Host Immunity

The COVID-19 pandemic is still posing a devastating threat to social life and economics. Despite the modest decrease in the number of cases during September–November 2020, the number of active cases is on the rise again. This increase was associated with the emergence and spread of the new SARS-CoV-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fakhroo, Aisha, AlKhatib, Hebah A., Al Thani, Asmaa A., Yassine, Hadi M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537829/ https://www.ncbi.nlm.nih.gov/pubmed/34696276 http://dx.doi.org/10.3390/vaccines9101168

Ejemplares similares

Will Host Genetics Affect the Response to SARS-CoV-2 Vaccines? Historical Precedents
por: Smatti, Maria K., et al.
Publicado: (2022)

Markers Associated with COVID-19 Susceptibility, Resistance, and Severity
por: Fakhroo, Aisha D., et al.
Publicado: (2020)

Epidemiological and genetic characterization of pH1N1 and H3N2 influenza viruses circulated in MENA region during 2009–2017
por: Al Khatib, Hebah A., et al.
Publicado: (2019)

Immunoinformatics prediction of potential immunodominant epitopes from human coronaviruses and association with autoimmunity
por: Mathew, Shilu, et al.
Publicado: (2022)

Within-Host Diversity of SARS-CoV-2 in COVID-19 Patients With Variable Disease Severities
por: Al Khatib, Hebah A., et al.
Publicado: (2020)

Inter-Versus Intra-Host Sequence Diversity of pH1N1 and Associated Clinical Outcomes
por: Al Khatib, Hebah A., et al.
Publicado: (2020)

Microbiome profiling of rotavirus infected children suffering from acute gastroenteritis
por: Sohail, Muhammad U., et al.
Publicado: (2021)

History of primary-series and booster vaccination and protection against Omicron reinfection
por: Chemaitelly, Hiam, et al.
Publicado: (2023)

Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2
por: Chemaitelly, Hiam, et al.
Publicado: (2022)

Profiling of Intestinal Microbiota in Patients Infected with Respiratory Influenza A and B Viruses
por: Al Khatib, Hebah A., et al.
Publicado: (2021)

Duration of immune protection of SARS-CoV-2 natural infection against reinfection
por: Chemaitelly, Hiam, et al.
Publicado: (2022)

Protection against Reinfection with the Omicron BA.2.75 Subvariant
por: Chemaitelly, Hiam, et al.
Publicado: (2023)

Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage
por: Chemaitelly, Hiam, et al.
Publicado: (2022)

Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infections
por: Abu-Raddad, Laith J., et al.
Publicado: (2022)

Vaccine evaluation and genotype characterization in children infected with rotavirus in Qatar
por: Mathew, Shilu, et al.
Publicado: (2023)

Epidemiology Profile of Viral Meningitis Infections Among Patients in Qatar (2015–2018)
por: Mathew, Shilu, et al.
Publicado: (2021)

Enhancing the sensitivity of rapid antigen detection test (RADT) of different SARS-CoV-2 variants and lineages using fluorescence-labeled antibodies and a fluorescent meter
por: Nasrallah, Gheyath K., et al.
Publicado: (2023)

Hepatitis B Virus Molecular Epidemiology, Host-Virus Interaction, Coinfection, and Laboratory Diagnosis in the MENA Region: An Update
por: Al-Sadeq, Duaa W., et al.
Publicado: (2019)

Computational screening of known broad-spectrum antiviral small organic molecules for potential influenza HA stem inhibitors
por: Mathew, Shilu, et al.
Publicado: (2018)

Viral-Induced Enhanced Disease Illness
por: Smatti, Maria K., et al.
Publicado: (2018)

Comparative analysis of within-host diversity among vaccinated COVID-19 patients infected with different SARS-CoV-2 variants
por: Al-Khatib, Hebah A., et al.
Publicado: (2022)

Molecular epidemiology of influenza, RSV, and other respiratory infections among children in Qatar: A six years report (2012–2017)
por: Al-Romaihi, Hamad E., et al.
Publicado: (2020)

Immune response variables and viral mutations impact on COVID-19 reinfection and relapse
por: Sanaie, Sarvin, et al.
Publicado: (2021)

Viruses and Autoimmunity: A Review on the Potential Interaction and Molecular Mechanisms
por: Smatti, Maria K., et al.
Publicado: (2019)

Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil
por: Fintelman-Rodrigues, Natalia, et al.
Publicado: (2021)

Variable VlsE Is Critical for Host Reinfection by the Lyme Disease Spirochete
por: Rogovskyy, Artem S., et al.
Publicado: (2013)

Impact of virus genetic variability and host immunity for the success of COVID-19 vaccines
por: dos Santos, Wagner Gouvêa
Publicado: (2021)

Metabolomics Approaches for the Diagnosis, Treatment, and Better Disease Management of Viral Infections
por: Al-Sulaiti, Haya, et al.
Publicado: (2023)

Epidemiology of respiratory infections among adults in Qatar (2012-2017)
por: Al-Romaihi, Hamad Eid, et al.
Publicado: (2019)

Antibiotic resistance and virulence patterns of pathogenic Escherichia coli strains associated with acute gastroenteritis among children in Qatar
por: Eltai, Nahla O., et al.
Publicado: (2020)

Detection of Antinuclear Antibodies Targeting Intracellular Signal Transduction, Metabolism, Apoptotic Processes and Cell Death in Critical COVID-19 Patients
por: Nasarallah, Gheyath K., et al.
Publicado: (2022)

Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational study
por: Qassim, Suelen H., et al.
Publicado: (2023)

Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort study
por: Chemaitelly, Hiam, et al.
Publicado: (2023)

Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta SARS-CoV-2 infections: an observational study
por: Altarawneh, Heba N., et al.
Publicado: (2023)

SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy
por: Abu-Raddad, Laith J., et al.
Publicado: (2021)

Mixed Viral-Bacterial Infections and Their Effects on Gut Microbiota and Clinical Illnesses in Children
por: Mathew, Shilu, et al.
Publicado: (2019)

Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting
por: Abu-Raddad, Laith J, et al.
Publicado: (2020)

Host Genetic Analysis Should Be Mandatory for Proper Classification of COVID-19 Reinfections
por: Pérez-Lago, Laura, et al.
Publicado: (2021)

Epidemiological, Molecular, and Clinical Features of Norovirus Infections among Pediatric Patients in Qatar
por: Mathew, Shilu, et al.
Publicado: (2019)

The Spectrum of Antibiotic Prescribing During COVID-19 Pandemic: A Systematic Literature Review
por: Al-Hadidi, Sara H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_edtfc3fmdgu5kvceu3cu3m3s7i